Robert Flaherty Joins Behrman Capital
Robert Flaherty has joined Behrman Capital as an operating partner, with a focus on the healthcare sector. He is the former CEO of Athena Diagnostics, which Behrman acquired and then sold to Fisher Scientific International for $283 million.



